MedMira Inc (MIR : TSX-V)
Common Stock
$0.06
CAD
+0.00 (%)
Last updated: 2026-10-19
Follow MIR
MIR
MedMira Inc
WealthAwesomePerformance
1 Day
+0.00%
1 Week
-7.69%
1 Month
-7.69%
YTD
-7.69%
Key Statistics
Market Cap
$42.10M
52W High
$0.09
52W Low
$0.05
P/E Ratio
-
50 Day MA
$0.07
200 Day MA
$0.07
Beta
0.78
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/19/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 10,000 |
| 10/16/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 103,022 |
| 10/15/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 83,000 |
| 10/14/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 0 |
| 10/13/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 11,000 |
| 10/8/2026 | $0.06 | $0.07 | $0.06 | $0.07 | $0.07 | 95,000 |
| 10/6/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 0 |
| 10/2/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 0 |
| 10/1/2026 | $0.07 | $0.07 | $0.06 | $0.06 | $0.06 | 16,049 |
| 9/28/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 20,100 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MIR's historical volatility
30-Day Vol
108.6%
Annualized
90-Day Vol
101.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 – C$0.08 |
| 60 trading days | C$0.05 | C$0.03 – C$0.09 |
| 90 trading days | C$0.05 | C$0.03 – C$0.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About MedMira Inc
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
Financials
- Revenue (TTM)
- $370,568
- EBITDA
- $-1.94M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- 0.00
- Book Value
- -0.04
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MIR
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| TNX | TenX Protocols Inc. | $51.36 | +42700.00% |
| IMPT | Impact Development Group Inc. | $0.01 | +200.00% |
| DRAX-P | Draxos Capital Corp. | $0.17 | +142.86% |
| DELX | DelphX Capital Markets Inc | $0.01 | +100.00% |
| RUN-H | Running Fox Resource Corp | $0.01 | +100.00% |
| RAC-P | Riverwalk Acquisition Corp. | $0.03 | +50.00% |
| AUTO | Agereh Technologies Inc | $0.04 | +40.00% |
| GGM | Granada Gold Mine Inc | $0.04 | +33.33% |
MIR.V news timeline
15 articles covering MIR.V, most recent first
Latest